Cardax Financial Statements From 2010 to 2024
| CDXI Stock | USD 0.0002 0.00 0.00% |
Check Cardax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardax main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Cardax financial statements analysis is a perfect complement when working with Cardax Valuation or Volatility modules.
Cardax |
Cardax Inc Company Shares Outstanding Analysis
Cardax's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cardax Shares Outstanding | 802.52 K |
Most of Cardax's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardax Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cardax Inc has 802.52 K of shares currently outstending. This is 99.56% lower than that of the Pharmaceuticals sector and 99.25% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.86% higher than that of the company.
Cardax Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cardax's current stock value. Our valuation model uses many indicators to compare Cardax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardax competition to find correlations between indicators driving Cardax's intrinsic value. More Info.Cardax Inc is rated below average in return on asset category among related companies. It is rated below average in operating margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cardax by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cardax's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardax's earnings, one of the primary drivers of an investment's value.About Cardax Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cardax income statement, its balance sheet, and the statement of cash flows. Cardax investors use historical funamental indicators, such as Cardax's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cardax investors may use each financial statement separately, they are all related. The changes in Cardax's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cardax's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cardax Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cardax. Please read more on our technical analysis and fundamental analysis pages.
Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Pair Trading with Cardax
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardax position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardax will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cardax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardax Inc to buy it.
The correlation of Cardax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardax Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cardax Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Cardax Pink Sheet analysis
When running Cardax's price analysis, check to measure Cardax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardax is operating at the current time. Most of Cardax's value examination focuses on studying past and present price action to predict the probability of Cardax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardax's price. Additionally, you may evaluate how the addition of Cardax to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets |